220 related articles for article (PubMed ID: 37927652)
1. Unique Properties of Yeast Probiotic Saccharomyces boulardii CNCM I-745: A Narrative Review.
Gopalan S; Ganapathy S; Mitra M; Neha ; Kumar Joshi D; Veligandla KC; Rathod R; Kotak BP
Cureus; 2023 Oct; 15(10):e46314. PubMed ID: 37927652
[TBL] [Abstract][Full Text] [Related]
2. Randomized, direct comparison study of Saccharomyces boulardii CNCM I-745 versus multi-strained Bacillus clausii probiotics for the treatment of pediatric acute gastroenteritis.
Altcheh J; Carosella MV; Ceballos A; D'Andrea U; Jofre SM; Marotta C; Mugeri D; Sabbaj L; Soto A; Josse C; Montestruc F; McFarland LV
Medicine (Baltimore); 2022 Sep; 101(36):e30500. PubMed ID: 36086703
[TBL] [Abstract][Full Text] [Related]
3. Saccharomyces boulardii CNCM I-745 in different clinical conditions.
Dinleyici EC; Kara A; Ozen M; Vandenplas Y
Expert Opin Biol Ther; 2014 Nov; 14(11):1593-609. PubMed ID: 24995675
[TBL] [Abstract][Full Text] [Related]
4. Saccharomyces boulardii CNCM I-745: A Non-bacterial Microorganism Used as Probiotic Agent in Supporting Treatment of Selected Diseases.
Kaźmierczak-Siedlecka K; Ruszkowski J; Fic M; Folwarski M; Makarewicz W
Curr Microbiol; 2020 Sep; 77(9):1987-1996. PubMed ID: 32472262
[TBL] [Abstract][Full Text] [Related]
5. Specific Probiotics for the Treatment of Pediatric Acute Gastroenteritis in India: A Systematic Review and Meta-Analysis.
McFarland LV; Srinivasan R; Setty RP; Ganapathy S; Bavdekar A; Mitra M; Raju B; Mohan N
JPGN Rep; 2021 Aug; 2(3):e079. PubMed ID: 37205949
[TBL] [Abstract][Full Text] [Related]
6. Saccharomyces boulardii CNCM I-745 reduces the duration of diarrhoea, length of emergency care and hospital stay in children with acute diarrhoea.
Dinleyici EC; Kara A; Dalgic N; Kurugol Z; Arica V; Metin O; Temur E; Turel O; Guven S; Yasa O; Bulut S; Tanir G; Yazar AS; Karbuz A; Sancar M; Erguven M; Akca G; Eren M; Ozen M; Vandenplas Y
Benef Microbes; 2015; 6(4):415-21. PubMed ID: 25653151
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy of
Maev IV; Andreev DN; Sokolov PS; Fomenko AК; Devkota MK; Andreev NG; Zaborovsky AV
Ter Arkh; 2022 Nov; 94(10):1163-1170. PubMed ID: 36468990
[TBL] [Abstract][Full Text] [Related]
8. Can the Evidence-Based Use of Probiotics (Notably Saccharomyces boulardii CNCM I-745 and Lactobacillus rhamnosus GG) Mitigate the Clinical Effects of Antibiotic-Associated Dysbiosis?
Waitzberg D; Guarner F; Hojsak I; Ianiro G; Polk DB; Sokol H
Adv Ther; 2024 Mar; 41(3):901-914. PubMed ID: 38286962
[TBL] [Abstract][Full Text] [Related]
9.
Duysburgh C; Van den Abbeele P; Morera M; Marzorati M
Benef Microbes; 2021 Aug; 12(4):59-73. PubMed ID: 34190033
[TBL] [Abstract][Full Text] [Related]
10. Probiotics for the prevention of pediatric antibiotic-associated diarrhea.
Goldenberg JZ; Lytvyn L; Steurich J; Parkin P; Mahant S; Johnston BC
Cochrane Database Syst Rev; 2015 Dec; (12):CD004827. PubMed ID: 26695080
[TBL] [Abstract][Full Text] [Related]
11. Growth, survival, and metabolic activities of probiotics Lactobacillus rhamnosus GG and Saccharomyces cerevisiae var. boulardii CNCM-I745 in fermented coffee brews.
Chan MZA; Toh M; Liu SQ
Int J Food Microbiol; 2021 Jul; 350():109229. PubMed ID: 34023682
[TBL] [Abstract][Full Text] [Related]
12. [Systematic review: clinical evidence of probiotics in the prevention of antibiotic-associated diarrhoea].
Storr M; Stengel A
MMW Fortschr Med; 2021 Apr; 163(Suppl 4):19-26. PubMed ID: 33844181
[TBL] [Abstract][Full Text] [Related]
13. Probiotics for the Prevention of Pediatric Antibiotic-Associated Diarrhea.
Hayes SR; Vargas AJ
Explore (NY); 2016; 12(6):463-466. PubMed ID: 27688016
[TBL] [Abstract][Full Text] [Related]
14. [Saccharomyces boulardii CNCM I-745 - the medicinal yeast improves intestinal enzyme function].
Moré MI
MMW Fortschr Med; 2019 Mar; 161(Suppl 4):20-24. PubMed ID: 30895510
[TBL] [Abstract][Full Text] [Related]
15. A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Saccharomyces boulardii in Infants and Children With Acute Diarrhea.
Mourey F; Sureja V; Kheni D; Shah P; Parikh D; Upadhyay U; Satia M; Shah D; Troise C; Decherf A
Pediatr Infect Dis J; 2020 Nov; 39(11):e347-e351. PubMed ID: 32796401
[TBL] [Abstract][Full Text] [Related]
16. Economic evaluation of S. boulardii CNCM I-745 for prevention of antibioticassociated diarrhoea in hospitalized patients.
Vermeersch SJ; Vandenplas Y; Tanghe A; Elseviers M; Annemans L
Acta Gastroenterol Belg; 2018; 81(2):269-276. PubMed ID: 30024698
[TBL] [Abstract][Full Text] [Related]
17. Probiotics for the prevention of pediatric antibiotic-associated diarrhea.
Johnston BC; Goldenberg JZ; Vandvik PO; Sun X; Guyatt GH
Cochrane Database Syst Rev; 2011 Nov; (11):CD004827. PubMed ID: 22071814
[TBL] [Abstract][Full Text] [Related]
18. Effect of
Ghosh A; Sundaram B; Bhattacharya P; Mohanty N; Dheivamani N; Mane S; Acharyya B; Kamale V; Poddar S; Khobragade A; Thomas W; Prabhudesai S; Choudhary A; Mitra M
Pediatr Gastroenterol Hepatol Nutr; 2021 Sep; 24(5):423-431. PubMed ID: 34557395
[TBL] [Abstract][Full Text] [Related]
19. Probiotics for the prevention of pediatric antibiotic-associated diarrhea.
Guo Q; Goldenberg JZ; Humphrey C; El Dib R; Johnston BC
Cochrane Database Syst Rev; 2019 Apr; 4(4):CD004827. PubMed ID: 31039287
[TBL] [Abstract][Full Text] [Related]
20. Diversity of
Czerucka D; Rampal P
World J Gastroenterol; 2019 May; 25(18):2188-2203. PubMed ID: 31143070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
